tiprankstipranks
Trending News
More News >

PainChek Ltd Reports Strong Sales Growth and Expands Market Presence

Story Highlights
PainChek Ltd Reports Strong Sales Growth and Expands Market Presence

Don’t Miss TipRanks’ Half-Year Sale

PainChek Ltd ( (AU:PCK) ) has shared an announcement.

PainChek Ltd reported significant quarterly sales growth, with a 9% increase in net contracted licenses and a 10% rise in contracted annual recurring revenue, reaching A$5.4 million. The company’s expansion across the UK, Australia, and Canada, along with positive outcomes from a Scottish Inspectorate validation study, underscores its strong market presence and potential for further integration into national healthcare frameworks. These developments highlight PainChek’s strategic positioning within the aged care sector and its effectiveness in improving patient outcomes.

More about PainChek Ltd

PainChek Ltd is a company specializing in the development of smart device-based pain assessment and monitoring applications. Their primary product, the PainChek app, is a regulatory-cleared medical device that facilitates best-practice pain management, particularly for individuals who cannot reliably self-report their pain. The app is available on smartphones and tablets and combines AI technology with the Numerical Rating Scale to provide accurate pain assessments. PainChek operates globally with regulatory clearance in several countries and is widely used in aged care facilities.

Average Trading Volume: 1,892,005

Technical Sentiment Signal: Buy

Current Market Cap: A$73.68M

For an in-depth examination of PCK stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1